Liberum Capital reaffirmed their buy rating on shares of Tate & Lyle (LON:TATE) in a research report report published on Tuesday morning. Liberum Capital currently has a GBX 850 ($12.17) price target on the stock.
TATE has been the subject of several other reports. Investec reiterated a buy rating and issued a GBX 735 ($10.52) target price on shares of Tate & Lyle in a report on Monday, January 29th. BNP Paribas decreased their target price on shares of Tate & Lyle from GBX 670 ($9.59) to GBX 660 ($9.45) and set a neutral rating for the company in a report on Thursday, April 5th. Kepler Capital Markets upgraded shares of Tate & Lyle to a buy rating and set a GBX 630 ($9.02) target price for the company in a report on Tuesday, February 13th. Deutsche Bank decreased their price target on shares of Tate & Lyle from GBX 725 ($10.38) to GBX 650 ($9.31) and set a hold rating for the company in a report on Monday, February 12th. Finally, Shore Capital restated a hold rating on shares of Tate & Lyle in a report on Tuesday, January 16th. Ten research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The company presently has a consensus rating of Hold and a consensus target price of GBX 716.62 ($10.26).
Shares of TATE opened at GBX 561 ($8.03) on Tuesday. Tate & Lyle has a one year low of GBX 539.40 ($7.72) and a one year high of GBX 796.50 ($11.40).
About Tate & Lyle
Tate & Lyle PLC, together with its subsidiaries, provides ingredients and solutions to the food, beverage, and other industries in the United States, the United Kingdom, other European countries, and internationally. It operates through two segments, Speciality Food Ingredients and Bulk Ingredients.
Receive News & Ratings for Tate & Lyle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tate & Lyle and related companies with MarketBeat.com's FREE daily email newsletter.